| EUROPA > EUR-Lex > ID celex

31999D0615


Title and reference

1999/615/JHA: Council Decision of 13 September 1999 defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties

  OJ L 244, 16.9.1999, p. 1–1 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
  CS.ES Chapter 19 Volume 01 P. 167
  ET.ES Chapter 19 Volume 01 P. 167
  HU.ES Chapter 19 Volume 01 P. 167
  LT.ES Chapter 19 Volume 01 P. 167
  LV.ES Chapter 19 Volume 01 P. 167
  MT.ES Chapter 19 Volume 01 P. 167
  PL.ES Chapter 19 Volume 01 P. 167
  SK.ES Chapter 19 Volume 01 P. 167
  SL.ES Chapter 19 Volume 01 P. 167

 DA  DE  EL  EN  ES  FI  FR  IT  NL  PT  SV

Text

ES CS DA DE ET EL EN FR IT LV LT HU MT NL PL PT SK SL FI SV
html html html html html html html html html html html html html html html html html html html html
  pdf     pdf         pdf pdf pdf pdf       pdf pdf    

Dates

Classifications

Miscellaneous information

Relationship between documents

Text

Bilingual display : CS DA DE EL EN ES ET FI FR HU IT LT LV MT NL PL PT SK SL SV

COUNCIL DECISION

of 13 September 1999

defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties

(1999/615/JHA)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union,

Having regard to Joint Action 97/396/JHA of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs(1), and in particular Article 5(1) thereof,

Having regard to the initiative of the Commission,

Whereas:

(1) A report was drawn up, on the basis of Article 4(3) of Joint Action 97/396/JHA, by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on the risk assessment of 4-MTA (P-Methylthioamphetamine or 4-Methylthioamphetamine);

(2) 4-MTA is an amphetamine derivative which appears to carry a higher risk of acute effects than MDMA (3,4-methylenedioxymethamphetamine) including adverse reactions and overdosage. In the European Union, it has been associated with a number of deaths and non-fatal cases requiring hospitalisation;

(3) 4-MTA has been identified as constituting a public health risk in serval Member States. It is at the moment subject to control in two Member States;

(4) 4-MTA is a potent psychoactive agent not currently listed in any of the Schedules to the 1971 United Nations Convention on Psychotropic Substances which poses a serious threat to public health, comparable to the substances listed in Schedules I or II thereto and has no apparent therapeutic value;

(5) In some Member States, the trafficking of 4-MTA in combination with other illegal substances has been discovered;

(6) 4-MTA should be subjected by the Member states to control measures and criminal penalties, as provided for under their legislation complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances with respect to substances listed in Schedules I or II thereto,

HAS DECIDED AS FOLLOWS:

Article 1

Member States shall take the necessary measures, in accordance with their national law, to submit 4-MTA (P-Methylthioamphetamine or 4-Methylthioamphetamine) to control measures and criminal penalties, as provided for under their legislation complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances with respect to substances listed in Schedules I or II thereto.

Article 2

Member States shall, in accordance with the third subparagraph of Article 5(1) of Joint Action 97/396/JHA, take the measures referred to in Article 1 within three months of the date on which this Decision takes effect.

Article 3

This Decision shall be published in the Official Journal.

It shall take effect on the day following that of its piblication.

Done at Brussels, 13 September 1999.

For the Council

The President

T. HALONEN

(1) OJ L 167, 25.6.1997, p. 1.

Top